Skip to main content
OpenTrials
Completed

NCT Number: NCT01055353

Evaluation of Target Organs Damage in Hypertensive Patients

Evaluation of target organs damage in hypertensive patients with no known cardiovascular (CV) or renal disease, stratified according to level of blood pressure control

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Target Organs Damage Hypertensive no Known Cardiovascular no Known Renal Disease

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Abbaretz, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosis of essential hypertension (treated or untreated); HT not discovered on the day of the consultation; no documented clinical cardiovascular or renal disease.

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. To evaluate the frequency of evaluation of preclinical target organs damage in hypertensive patients with no known cardiovascular or renal disease, by taking blood pressure (controlled or uncontrolled HT*) into account

    Time frame: once / 1 Year

Secondary outcomes

  1. To describe the patient profile (socio-demographic, risk factors, comorbidities, global CV risk level estimated by the doctor and calculated retrospectively [according to ESH 2007]) associated with screening for target organs damage

  2. To describe the modalities of patient follow-up and management

  3. To compare the frequency of evaluation of target organs damage as a function of the modalities of management of CV risk factors at the time of the consultation.

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Evaluation of Target Organs Damage in Hypertensive Patients Followed in General Practice With no Known Cardiovascular (CV) or Renal Disease, Stratified According to Blood Pressure Control

Acronym: PreVENT-A GP

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Jan 25, 2010
Registry last updated
May 12, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.